Industry
Business classification
VCID: 421421
Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Investments
Investment preferences
Selected investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
Judo Bio Inc Developer of oligonucleotide medicines delivered to the kidney. |
United States | 7 Oct 2024 | Series A Initial investment. Round participant. Active |
|
|
Avelas Biosciences Inc Provider of advance, new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons. |
United States | 18 Aug 2016 | Series C Round participant. Active |